198 related articles for article (PubMed ID: 35080453)
21. Comparison of Lung-RADS Version 1.1 and Lung-RADS Version 2022 in Classifying Airway Nodules Detected at Lung Cancer Screening CT.
DeSimone AK; Byrne SC; Hammer MM
Radiol Cardiothorac Imaging; 2024 Feb; 6(1):e230149. PubMed ID: 38300115
[TBL] [Abstract][Full Text] [Related]
22. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
[TBL] [Abstract][Full Text] [Related]
23. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.
Silvestri GA; Goldman L; Tanner NT; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Fedewa S
Chest; 2023 Jul; 164(1):241-251. PubMed ID: 36773935
[TBL] [Abstract][Full Text] [Related]
24. The Lung Reporting and Data System (LU-RADS): a proposal for computed tomography screening.
Manos D; Seely JM; Taylor J; Borgaonkar J; Roberts HC; Mayo JR
Can Assoc Radiol J; 2014 May; 65(2):121-34. PubMed ID: 24758919
[TBL] [Abstract][Full Text] [Related]
25. Performance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort.
Kessler A; Peng R; Mardakhaev E; Haramati LB; White CS
Radiol Imaging Cancer; 2020 Mar; 2(2):e190021. PubMed ID: 33778703
[TBL] [Abstract][Full Text] [Related]
26. Interobserver variability in Lung CT Screening Reporting and Data System categorisation in subsolid nodule-enriched lung cancer screening CTs.
Yoon SH; Kim YJ; Doh K; Kim J; Lee KH; Lee KW; Kim J
Eur Radiol; 2021 Sep; 31(9):7184-7191. PubMed ID: 33733688
[TBL] [Abstract][Full Text] [Related]
27. Lung Cancer Screening in Clinical Practice: A 5-Year Review of Frequency and Predictors of Lung Cancer in the Screened Population.
Lafata KJ; Read C; Tong BC; Akinyemiju T; Wang C; Cerullo M; Tailor TD
J Am Coll Radiol; 2024 May; 21(5):767-777. PubMed ID: 37952807
[TBL] [Abstract][Full Text] [Related]
28. Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial.
White CS; Dharaiya E; Dalal S; Chen R; Haramati LB
Radiology; 2019 Apr; 291(1):205-211. PubMed ID: 30667335
[TBL] [Abstract][Full Text] [Related]
29. Application of computer-aided diagnosis for Lung-RADS categorization in CT screening for lung cancer: effect on inter-reader agreement.
Park S; Park H; Lee SM; Ahn Y; Kim W; Jung K; Seo JB
Eur Radiol; 2022 Feb; 32(2):1054-1064. PubMed ID: 34331112
[TBL] [Abstract][Full Text] [Related]
30. Invasive Procedures Associated With Lung Cancer Screening in Clinical Practice.
Manyak A; Seaburg L; Bohreer K; Kirtland SH; Hubka M; Gerbino AJ
Chest; 2023 Aug; 164(2):544-555. PubMed ID: 36781101
[TBL] [Abstract][Full Text] [Related]
31. Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals.
Landy R; Wang VL; Baldwin DR; Pinsky PF; Cheung LC; Castle PE; Skarzynski M; Robbins HA; Katki HA
JAMA Netw Open; 2023 Mar; 6(3):e233273. PubMed ID: 36929398
[TBL] [Abstract][Full Text] [Related]
32. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
[TBL] [Abstract][Full Text] [Related]
33. Lung-RADS Version 1.1: Challenges and a Look Ahead, From the
Chelala L; Hossain R; Kazerooni EA; Christensen JD; Dyer DS; White CS
AJR Am J Roentgenol; 2021 Jun; 216(6):1411-1422. PubMed ID: 33470834
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Alternative Diagnostic Follow-up Intervals for Lung Reporting and Data System Criteria on the Effectiveness of Lung Cancer Screening.
Bastani M; Toumazis I; Hedou' J; Leung A; Plevritis SK
J Am Coll Radiol; 2021 Dec; 18(12):1614-1623. PubMed ID: 34419477
[TBL] [Abstract][Full Text] [Related]
35. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.
Strigel RM; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski LR; DeMartini WB
AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Positive and Suspicious Findings in Clinical Computed Tomography Lung Cancer Screening and the Road Ahead.
Regis SM; Borondy-Kitts A; McKee AB; Rieger-Christ K; Sands J; Afnan J; McKee BJ
Ann Am Thorac Soc; 2022 Aug; 19(8):1371-1378. PubMed ID: 34818144
[No Abstract] [Full Text] [Related]
37. A Decision Analysis of Follow-up and Treatment Algorithms for Nonsolid Pulmonary Nodules.
Hammer MM; Palazzo LL; Eckel AL; Barbosa EM; Kong CY
Radiology; 2019 Feb; 290(2):506-513. PubMed ID: 30457486
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ultra-low dose chest CT scanning protocols for the detection of pulmonary nodules: a phantom study.
Milanese G; Silva M; Frauenfelder T; Eberhard M; Sabia F; Martini C; Marchianò A; Prokop M; Sverzellati N; Pastorino U
Tumori; 2019 Oct; 105(5):394-403. PubMed ID: 31041885
[TBL] [Abstract][Full Text] [Related]
39. Performance of ACR Lung-RADS in a clinical CT lung screening program.
McKee BJ; Regis SM; McKee AB; Flacke S; Wald C
J Am Coll Radiol; 2015 Mar; 12(3):273-6. PubMed ID: 25176499
[TBL] [Abstract][Full Text] [Related]
40. Observer variability for Lung-RADS categorisation of lung cancer screening CTs: impact on patient management.
van Riel SJ; Jacobs C; Scholten ET; Wittenberg R; Winkler Wille MM; de Hoop B; Sprengers R; Mets OM; Geurts B; Prokop M; Schaefer-Prokop C; van Ginneken B
Eur Radiol; 2019 Feb; 29(2):924-931. PubMed ID: 30066248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
